319 related articles for article (PubMed ID: 22310284)
1. New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy.
Long JS; Ryan KM
Oncogene; 2012 Dec; 31(49):5045-60. PubMed ID: 22310284
[TBL] [Abstract][Full Text] [Related]
2. Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.
Emdad L; Bhoopathi P; Talukdar S; Pradhan AK; Sarkar D; Wang XY; Das SK; Fisher PB
Semin Cancer Biol; 2020 Nov; 66():140-154. PubMed ID: 31356866
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapeutic approaches for targeting cell death pathways.
Ricci MS; Zong WX
Oncologist; 2006 Apr; 11(4):342-57. PubMed ID: 16614230
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapeutic targeting of cell death pathways.
Mansilla S; Llovera L; Portugal J
Anticancer Agents Med Chem; 2012 Mar; 12(3):226-38. PubMed ID: 22263795
[TBL] [Abstract][Full Text] [Related]
5. From nature to bedside: pro-survival and cell death mechanisms as therapeutic targets in cancer treatment.
Cerella C; Teiten MH; Radogna F; Dicato M; Diederich M
Biotechnol Adv; 2014 Nov; 32(6):1111-22. PubMed ID: 24681093
[TBL] [Abstract][Full Text] [Related]
6. Modulating autophagy in cancer therapy: Advancements and challenges for cancer cell death sensitization.
Bhat P; Kriel J; Shubha Priya B; Basappa ; Shivananju NS; Loos B
Biochem Pharmacol; 2018 Jan; 147():170-182. PubMed ID: 29203368
[TBL] [Abstract][Full Text] [Related]
7. FLIP as a therapeutic target in cancer.
Humphreys L; Espona-Fiedler M; Longley DB
FEBS J; 2018 Nov; 285(22):4104-4123. PubMed ID: 29806737
[TBL] [Abstract][Full Text] [Related]
8. Role of autophagy in regulation of cancer cell death/apoptosis during anti-cancer therapy: focus on autophagy flux blockade.
Tilija Pun N; Jang WJ; Jeong CH
Arch Pharm Res; 2020 May; 43(5):475-488. PubMed ID: 32458284
[TBL] [Abstract][Full Text] [Related]
9. [The types of cell death].
Stepień A; Izdebska M; Grzanka A
Postepy Hig Med Dosw (Online); 2007 Jul; 61():420-8. PubMed ID: 17679912
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis-modulating drugs for improved cancer therapy.
Ocker M; Höpfner M
Eur Surg Res; 2012; 48(3):111-20. PubMed ID: 22538523
[TBL] [Abstract][Full Text] [Related]
11. Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target.
Radogna F; Dicato M; Diederich M
Biochem Pharmacol; 2015 Mar; 94(1):1-11. PubMed ID: 25562745
[TBL] [Abstract][Full Text] [Related]
12. Molecular Cell Biology of Apoptosis and Necroptosis in Cancer.
Dillon CP; Green DR
Adv Exp Med Biol; 2016; 930():1-23. PubMed ID: 27558815
[TBL] [Abstract][Full Text] [Related]
13. Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patent documents.
Ralph SJ; Low P; Dong L; Lawen A; Neuzil J
Recent Pat Anticancer Drug Discov; 2006 Nov; 1(3):327-46. PubMed ID: 18221044
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species and autophagy modulation in non-marine drugs and marine drugs.
Farooqi AA; Fayyaz S; Hou MF; Li KT; Tang JY; Chang HW
Mar Drugs; 2014 Nov; 12(11):5408-24. PubMed ID: 25402829
[TBL] [Abstract][Full Text] [Related]
15. Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents.
Zhang X; Chen LX; Ouyang L; Cheng Y; Liu B
Cell Prolif; 2012 Oct; 45(5):466-76. PubMed ID: 22765290
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic exploitation of apoptosis and autophagy for glioblastoma.
Kögel D; Fulda S; Mittelbronn M
Anticancer Agents Med Chem; 2010 Jul; 10(6):438-49. PubMed ID: 20879985
[TBL] [Abstract][Full Text] [Related]
17. Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development.
Jain MV; Paczulla AM; Klonisch T; Dimgba FN; Rao SB; Roberg K; Schweizer F; Lengerke C; Davoodpour P; Palicharla VR; Maddika S; Łos M
J Cell Mol Med; 2013 Jan; 17(1):12-29. PubMed ID: 23301705
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic and autophagic pathways with relevant small-molecule compounds, in cancer stem cells.
Zhang L; Tong X; Li J; Huang Y; Hu X; Chen Y; Huang J; Wang J; Liu B
Cell Prolif; 2015 Aug; 48(4):385-97. PubMed ID: 26013704
[TBL] [Abstract][Full Text] [Related]
19. Oridonin: targeting programmed cell death pathways as an anti-tumour agent.
Liu Z; Ouyang L; Peng H; Zhang WZ
Cell Prolif; 2012 Dec; 45(6):499-507. PubMed ID: 23106297
[TBL] [Abstract][Full Text] [Related]
20. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents.
Sui X; Kong N; Ye L; Han W; Zhou J; Zhang Q; He C; Pan H
Cancer Lett; 2014 Mar; 344(2):174-9. PubMed ID: 24333738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
